Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under License Agreement with Roche
Milestone in the amount of $50 million realizedBOSTON, June 16, 2021 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”),...
pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026